Devices and methods for the treatment of tissue
Systems, methods and devices for the treatment of tissue are disclosed. A system includes an elongate tube with a distal portion. A treatment element is positioned on the elongate tube distal portion, the treatment element constructed and arranged to treat target tissue. In one embodiment, gastrointestinal tissue is modified for the treatment of diabetes.
1. A method of treating a mucosal layer of a patient's duodenum, said method comprising:
providing a system including a tissue expansion device and a separate treatment element constructed and arranged to expand and treat a full circumferential portion of a mucosal target tissue in the duodenum;
positioning the tissue expansion device at a treatment location distal of the pylorus and proximal of the ligament of Treitz;
expanding a full circumferential portion of a mucosal target tissue in the duodenum using the tissue expansion device;
moving the tissue expansion device from the treatment location;
positioning the treatment element to contact the expanded full circumferential portion of the mucosal target tissue at the treatment location distal of the pylorus and proximal of the ligament of Treitz while avoiding contact with non-target tissue;
treating target tissue at the treatment location with the treatment element, wherein treating comprises delivering energy to said treatment location;
wherein the treatment element comprises a conformable balloon constructed and arranged to receive hot fluid and wherein treating the target tissue comprises expanding the balloon with the hot fluid to conform the balloon to engage luminal wall tissue to modify modifies at least one property selected from the group of properties consisting of secretive properties and absorptive properties of the portion of the gastrointestinal tract and wherein treating comprises positioning a protective cap over the Ampulla of Vater to prevent bile salts from emptying into the duodenum and to avoid adversely affecting non-target tissue including at least the ampulla of Vater and removing the protective cap.
2. The method of claim 1 wherein the patient is being treated for a disease or disorder selected from the group consisting of Diabetes; Type-1 Diabetes; Type-2 Diabetes; hypercholesterolemia; a metabolic syndrome; celiac disease; obesity; cancer; bronchoalveolar carcinoma; cystitis; and combinations thereof.
3. The method of claim 1 wherein the target tissue includes multiple adjacent segments of the gastrointestinal tract within the portion of the gastrointestinal tract spanning from the pylorus to the ligament of Treitz.
4. The method of claim 1 wherein target tissue treatment causes the target tissue to be replaced with new tissue.
5. The method of claim 4 wherein the new tissue displays different secretive properties than the target tissue.
6. The method of claim 4 wherein the new tissue displays different absorptive properties than the target tissue.
7. The method of claim 4 wherein the new tissue comprises new mucosal cells that have migrated from at least one of the gastric mucosa or the jejunal mucosa.
8. The method of claim 1 wherein the target tissue further comprises stem cells at a base of crypts of the duodenal mucosal tissue.
9. The method of claim 1 wherein the target tissue further comprises submucosal tissue.
10. The method of claim 1 wherein the non-target tissue is further selected from the group consisting of tunica serosa of the intestine; pancreas; tunica muscularis of the intestine; outermost partial layer of the submucosa of the intestine; bile duct; pylorus; Sphincter of Oddi; and combinations thereof.
11. The method of claim 1 wherein the target tissue comprises a first portion and a second portion, and wherein the target tissue treatment comprises treating the first portion and subsequently treating the second portion.
12. The method of claim 11 wherein the first portion and the second portion comprise at least one of overlapping portions of tissue or adjacent portions of tissue.
13. The method of claim 1 wherein treating the target tissue comprises causing at least one of cell death; apoptosis; instant cell death; cell necrosis; denaturing of cells; removal of cells; and combinations thereof.
14. The method of claim 1 further comprising selecting the target tissue to be treated.
15. The method of claim 14 wherein selecting is based on one or more of a patient disease; a patient disorder; a patient anatomical condition; a patient physiologic condition; gross anatomical borders of the target tissue; functional borders of the target tissue; and combinations thereof.
16. The method of claim 14 wherein selecting is based on a patient physiologic condition selected from the group consisting of: hyperglycemic hyperosmolar state; diabetic ketoacidosis; insulin resistance; pre-diabetes; hypertriglyceridemia; and combinations thereof.
17. The method of claim 1 further comprising expanding the treatment element prior to treating the target tissue.
18. The method of claim 1 wherein the hot fluid comprises fluid at a temperature of approximately 65° C. to 90° C.
19. The method of claim 1 wherein the target tissue comprises a first portion and a second portion and wherein the target tissue treatment comprises delivering a first energy delivery to the first portion of target tissue and a second energy delivery to the second portion of target tissue.
20. The method of claim 1 wherein the tissue expansion device comprises one or more fluid delivery elements.
21. The method of claim 1 wherein expanding a full circumferential portion of a mucosal target tissue comprises delivering fluid into tissue to cause circumferential expansion of the portion of the gastrointestinal tract.
22. The method of claim 1 further comprising pressurizing the portion of the gastrointestinal tract.
23. The method of claim 1 , wherein the protective cap is removed within twenty four hours of placement in the patient.
24. The method of claim 1 , wherein the protective cap is placed and removed with an endoscope.